October 2, 2020

New White Paper: A Cell-based ADCC Bioassay Comparison

The surge in interest for developing therapeutic antibodies in the last few years has led to increased demand for reliable cell-based assays to assess the ability of these antibodies to elicit ADCC.

In this white paper, we present data on the quantification of ADCC using cell-based iLite ADCC bioassays. In addition, we compare this technology to a traditional method based on NFAT effector cells and wild-type target cells.

 

Download the paper

October 2, 2020

New White Paper: A Cell-based ADCC Bioassay Comparison

The surge in interest for developing therapeutic antibodies in the last few years has led to increased demand for reliable cell-based assays to assess the ability of these antibodies to elicit ADCC.

In this white paper, we present data on the quantification of ADCC using cell-based iLite ADCC bioassays. In addition, we compare this technology to a traditional method based on NFAT effector cells and wild-type target cells.

 

Download the paper